– ISRAEL, Yokneam – Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, today announced the appointment of Daniel Levangie to its Board of Directors.
“We are thrilled to welcome Dan. Dan brings vast commercial experience, a deep perspective, and proven capabilities to our Board of Directors. His expertise will be invaluable and will complement the skills of our existing board members as we continue to grow and scale our company. I look forward to working with Dan,” said Board chairman, Dr. Shimon Eckhouse.
Mr. Levangie is the Chairman, CEO, and co-founder of Cerevasc, Inc., as well as the co-founder and Managing Partner of ATON Partners. In addition, he is a member of the Board of Directors of Exact Sciences, Inc. and Renovia, Inc. His long-term interest in the stroke treatment market started during his tenure as the Chairman of ev3 before its acquisition by Covidien.
“I am excited to join such a dynamic and mission-driven company,” said Dan. “Rapid Medical’s technology is a game-changer in neurovascular intervention. Through its innovative technology, its devices are fully adjustable in the brain. This means the devices are equipped to handle a broader range of patient anatomies and situations. I am looking forward to the opportunity to build a strong business with a significant impact on the lives of stroke patients.”
About Rapid Medical
Rapid Medical develops premier responsive interventional devices for endovascular diseases such as ischemic and hemorrhagic stroke. Utilizing novel manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the intravascular environment and have greater control over procedural outcomes.
For more information: https://www.rapid-medical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.